RXST RxSight Inc
138
$33.56
$0.57
(1.73%)
| Market Cap | $1.2B |
| Volume (M) | 636,744.00 |
| 52-Wk High | $33.98 |
| 52-Wk Low | $10.29 |
ST Data
Watchers
New Watcher Rank
RxSight (NASDAQ:RXST) Now Covered by Analysts at Morgan StanleyZolmax • 1 day ago
Morgan Stanley began coverage on shares of RxSight (NASDAQ:RXST Free Report) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage issued an overweight...
Share to Feed
Those holding RxSight, Inc. ( NASDAQ:RXST ) shares would be relieved that the share price has rebounded 28% in the last...
American International Group Inc. increased its stake in shares of RxSight, Inc. (NASDAQ:RXST Free Report) by 13.8% during the 2nd quarter, Holdings Channel reports. The institutional...
RxSight, Inc. (NASDAQ:RXST Get Free Report) Director Bakker Juliet Tammenoms sold 100,000 shares of the companys stock in a transaction dated Tuesday, November 14th. The stock was sold...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
RxSight (NASDAQ:RXST Get Free Report) had its price target dropped by analysts at Needham Company LLC from $36.00 to $30.00 in a research report issued to clients and investors on...
Analyst Ryan Zimmerman of BTIG reiterated a Buy rating on RxSight (RXST Research Report), with a price target of $36.00. Ryan Zimmerman has given...
ALISO VIEJO, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
ALISO VIEJO, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients...
Investors considering a purchase of RxSight Inc (RXST) shares, but cautious about paying the going market price of 21.30/share, might benefit from considering selling puts among the alternative...
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.
Latest RXST News
RxSight (NASDAQ:RXST) Now Covered by Analysts at Morgan Stanley
Zolmax • 1 day ago
Revenues Tell The Story For RxSight, Inc. (NASDAQ:RXST) As Its Stock Soars 28%
Simply Wall St • 13 days ago
American International Group Inc. Has $376,000 Stock Holdings in RxSight, Inc. (NASDAQ:RXST)
Zolmax • 17 days ago